L. E. Arnold

发表

Neurochemical correlates of autistic disorder: a review of the literature.

L. E. Arnold, M. Aman, Kristen S. L. Lam, 2006, Research in developmental disabilities.

Dietary Sensitivities and ADHD Symptoms: Thirty-five Years of Research

T. Kuczek, L. E. Arnold, J. Burgess, 2011, Clinical pediatrics.

Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Irritability: Results From the Multimodal Treatment Study of Children With ADHD (MTA)

Jeffrey M. Halperin, Argyris Stringaris, Emily Simonoff, 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Tristram H. Smith, J. Hellings, X. Pan, 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.

C. McDougle, S. Caprio, L. Scahill, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

Factor Validity of a Proactive and Reactive Aggression Rating Scale

C. Farmer, R. Findling, L. E. Arnold, 2014, Journal of Child and Family Studies.

Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

Xiaobai Li, C. Farmer, L. E. Arnold, 2012, Journal of child and adolescent psychopharmacology.

Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

C. McDougle, F. Volkmar, J. Leckman, 2011, Journal of child and adolescent psychopharmacology.

Cognitive effects of risperidone in children with autism and irritable behavior.

C. McDougle, D. Posey, L. Ritz, 2008, Journal of child and adolescent psychopharmacology.

Differences in verbal and nonverbal IQ test scores in children with autism spectrum disorder

C. McDougle, L. Scahill, L. E. Arnold, 2018 .

A Multisite Trial of Atomoxetine and Parent Training in Children with Autism Spectrum Disorders: Rationale and Design Challenges.

Tristram H. Smith, Xiaobai Li, X. Pan, 2014, Research in autism spectrum disorders.

Behavioral and Emotional Problems Associated With Convergence Insufficiency in Children

S. Cotter, E. Borsting, C. Chase, 2016, Journal of attention disorders.

Review of serotonergic agents and perseverative behavior in patients with developmental disabilities

L. E. Arnold, M. Aman, S. Armstrong, 1999 .

Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.

C. Farmer, B. Molina, R. Findling, 2015, Journal of child and adolescent psychopharmacology.

High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders.

D. Lane, K. Loveland, D. Pearson, 2012, Journal of child and adolescent psychopharmacology.

A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.

Tristram H. Smith, X. Pan, B. Handen, 2018, Journal of child and adolescent psychopharmacology.

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

C. McDougle, D. Posey, F. Volkmar, 2001, Journal of child and adolescent psychopharmacology.

The treatment of severe child aggression (TOSCA) study: Design challenges

Xiaobai Li, C. Farmer, R. Findling, 2011, Child and adolescent psychiatry and mental health.

Medication and Parent Training in Children with Pervasive Developmental Disorders and Serious Behavior Problems: Results from a Randomized Clinical Trial Research Units on Pediatric Psychopharmacology Autism Network *

C. McDougle, B. Vitiello, E. Butter, 2011 .

Trial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders

C. McDougle, L. Ritz, J. McCracken, 2009, Journal of autism and developmental disorders.